Business NewsPR NewsWire • New EU-Funded Consortium to Develop Fully Personalized Cancer Vaccines for Brain Cancer Patients

New EU-Funded Consortium to Develop Fully Personalized Cancer Vaccines for Brain Cancer Patients

New EU-Funded Consortium to Develop Fully Personalized Cancer Vaccines for Brain Cancer Patients

MAINZ, Germany, July 4, 2013 /PRNewswire/ -- Glioma Actively Personalized Vaccine Consortium (GAPVAC): 14 organizations in Europe and the US join forces to develop a completely novel approach to fight cancer Multi-national clinical trial treating glioblastoma patients with fully...

View More : http://www.prnewswire.com/news-releases/new-eu-funded-consortium-to-develop-fully-personalized-cancer-vaccines-for-brain...
Releted News by prnewswire
New EU-Funded Consortium to Develop Fully Personalized Cancer Vaccines for Brain Cancer Patients
Northrop Grumman Exhibits at Waddington International Air Show, RAF Waddington, UK
Stahl+Metall AG wird zertifizierter Partner von Ruukki in der Schweiz